Anavex Life Sciences
AVXL
#9426
Rank
S$0.18 B
Marketcap
S$1.96
Share price
2.68%
Change (1 day)
-82.47%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -S$16.61 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$51.23 Million, an increase over its 2024 earnings that were of -S$66.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$16.61 Million-67.59%
2025 -S$51.23 Million-22.43%
2024 -S$66.04 Million14.77%
2023 -S$57.55 Million-17.49%
2022 -S$69.74 Million22.96%
2021 -S$56.72 Million35.36%
2020 -S$41.9 Million12.65%
2019 -S$37.2 Million29.09%
2018 -S$28.82 Million36.33%
2017 -S$21.14 Million17.11%
2016 -S$18.05 Million20.91%
2015 -S$14.93 Million-6.29%
2014 -S$15.93 Million337.28%
2013 -S$3.65 Million
2008 -S$6.74 Million106.01%
2007 -S$3.27 Million8848.98%
2006 -S$0.04 Million-79.99%
2005 -S$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
S$0.31 B-1,984.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$8.2 M-149.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$8 Million-51.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$0.49 Billion 2,842.85%๐Ÿ‡บ๐Ÿ‡ธ USA